[Clinical effectiveness of Marvelon].
Clinical results of a new contraceptive pills--Marvelon (Organon) were studied. 32 women, ages 30 +/- 5 years, participated in the study during at least 6 cycles. Marvelon was good tolerated and subjective side-effects were very low. The cycles were regular, duration of withdrawal bleeding was 3-5 days and the amount of the blood lost were unchanged or milder. Marvelon didn't affect body weight and blood pressure. Favourable lipid profile--increased a mean level of HDL-Cholesterol and decreased a mean level of LDL-Cholesterol were noticed. Pearl Index was 0,0.
Marianowski
L
L
I Katedry i Kliniki Połoznictwa i Ginekologii AM w Warszawie.
Grzechocińska
B
B
D000328:Adult; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects; D003280:Contraceptives, Oral, Synthetic / Q000494:pharmacology; D017135:Desogestrel / Q000494:pharmacology; D005260:Female; D006801:Humans; D008597:Menstrual Cycle / Q000187:drug effects
D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D003280:Contraceptives, Oral, Synthetic; D017135:Desogestrel
Analiza kliniczna stosowania Marvelonu.